One-pot synthesis of poly(alkyl methacrylate)-functionalized mesoporous silica hybrid nanocomposites for microencapsulation of poorly soluble phytochemicals
Source abstract
Abstract
Abstract Silibinin (SBN), the major active constituent of milk thistle seeds indicated in liver conditions, has low oral bioavailability due to low solubility and degradation in gastric fluid. Hybrid mesoporous silica nanocomposites composed of polymerized alkyl methacrylate monomers (methyl methacrylate, butyl methacrylate or 1:1 mixture of methyl methacrylate and acrylic acid) were developed to enhance dissolution and antioxidant activity of SBN. Samples were worked up by calcination in oven or refluxing with ammonium nitrate. DLS, FE-SEM, AFM, TGA, FTIR, EDS, XRD and BET techniques were employed to characterize unloaded and SBN-loaded particles. Well-tuned hybrid nanoparticles exhibited spherical morphology, small size (~20 nm), large pore volumes (1.6 cm3g−1), high polymer functionality (~50%) and high SBN loading (19%). Importantly, in-vitro dissolution and DPPH antioxidant activity of SBN in acidic gastric medium increased remarkably after loading in the particles. Conclusively, well-tuned hybrid nanocomposites are suggested for modulating the oral bioavailability of poorly sluble phytochemicals.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Silymarin and Mushroom Poisoning · Analytical Chemistry and Chromatography · Essential Oils and Antimicrobial Activity
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (62)
Show source-provided references
1. Phosphate-linked silibinin dimers (PLSd): new promising modified metabolites10.3390/molecules22081323 ↗
2. Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes10.1111/j.0901-9928.2000.860602.x ↗
3. Oral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles10.1016/j.actbio.2012.02.011 ↗
4. Reassessing bioavailability of silymarin
5. Stabilisation and controlled release of silibinin from pH responsive shellac colloidal particles10.1039/c1sm05853c ↗
6. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos)
7. Solid state mechanochemical activation of Silybum marianum dry extract with betacyclodextrins: characterization and bioavailability of the coground systems10.1002/jps.21704 ↗
8. Clinical efficacy, safety and tolerability of BIO-C®(micronizedSilymarin) as a galactagogue
9. Micronization of silybin by the emulsion solvent diffusion method10.1016/j.ijpharm.2009.04.028 ↗
10. Preparation and pharmacological evaluation of silibinin liposomes
11. Preparation of silymarin-loaded amphiphilic chitosan micelle and its in situ absorption in rat intestine
12. Oil based nanocarrier for improved oral delivery of silymarin: in vitro and in vivo studies10.1016/j.ijpharm.2011.04.041 ↗
13. Effect of silybin and its glycosides on the expression of cytochromes P450 1A2 and 3A4 in primary cultures of human hepatocytes10.1002/jbt.20066 ↗
14. Formulation, characterization, and in vitro evaluation of silymarin-loaded lipid microspheres10.1080/10717540490433958 ↗
15. Freeze-drying of silymarin-loaded solid lipid nanoparticles (SM-SLN)
16. Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in vitro release kinetics and in vitro/in vivo correlations in beagle dogs10.1016/j.ejps.2012.10.012 ↗
17. A review: fundamental aspects of silicate mesoporous materials10.3390/ma5122874 ↗
18. Recent advancements in silica nanoparticles based technologies for removal of dyes from water10.1016/j.colcom.2019.100181 ↗
19. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs10.1016/j.jconrel.2005.08.017 ↗
20. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers10.1016/j.addr.2008.03.012 ↗
21. Functionalized mesoporous silica materials for controlled drug delivery10.1039/c2cs15308d ↗
22. Interfacial phenomena in composites with nanostructured succinic acid bound to hydrophilic and hydrophobic nanosilicas10.1016/j.colcom.2020.100251 ↗
23. Gold nanoparticles deposited on silica microparticles-Electrokinetic characteristics and application in SERS10.1016/j.colcom.2019.100219 ↗
24. Ordered mesoporous polymers of tunable pore size from colloidal silica templates10.1126/science.283.5404.963 ↗
25. Synthesis of spherical mesoporous silica nanoparticles with nanometer-size controllable pores and outer diameters10.1016/j.micromeso.2008.12.019 ↗
26. Evaluating the internal structure of monodispersed mesoporous silica spheres by small-angle X-ray scattering10.1016/j.colcom.2019.100203 ↗
27. Influence of pore size of MCM-41 matrices on drug delivery rate10.1016/j.micromeso.2003.12.012 ↗
28. Encapsulation of polymers in CTA-MCM-41 via microemulsion10.1016/j.micromeso.2013.05.010 ↗
29. Action of silicic acid derived from sodium silicate precursor toward improving performances of porous gelatin membrane10.1002/app.48912 ↗
30. Hybrid organic/inorganic dendritic triblock copolymers: Synthesis, nanostructure characterization, and micellar behavior10.1002/app.31805 ↗
31. Effect of anionic polymers on drug loading and release from clindamycin phosphate solid lipid nanoparticles
32. Application of hybrid organic/inorganic dendritic ABA type triblock copolymers as new nanocarriers in drug delivery systems10.1080/00914037.2010.531824 ↗
33. The search of a homogeneously dispersed material—the art of handling the organic polymer/metal oxide interface10.1007/s10971-008-1731-2 ↗
34. Influence of anchoring segments on methacrylate-based comb-type hydrophilic polymer segments coated on silica surfaces using the grafting-to method10.1016/j.colcom.2020.100258 ↗
35. Enhancement of oral bioavailability of poorly water-soluble drugs by poly (ethylene glycol)-block-poly (alkyl acrylate-co-methacrylic acid) self-assemblies10.1016/j.jconrel.2005.02.010 ↗
36. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly (methyl methacrylate) nanoparticles10.1021/bm900035u ↗
37. Intracellular ROS protection efficiency and free radical-scavenging activity of quercetin and quercetin-encapsulated liposomes10.3109/21691401.2014.926456 ↗
38. Effects of surface modification and size on oral drug delivery of mesoporous silica formulation10.1016/j.jcis.2017.11.065 ↗
39. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles10.1002/smll.200900005 ↗
40. The effects on pore size and particle morphology of heptane additions to the synthesis of mesoporous silica SBA-1510.1016/j.micromeso.2010.04.016 ↗
41. Universal emulsion stabilization from the arrested adsorption of rough particles at liquid-liquid interfaces10.1038/ncomms15701 ↗
42. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells10.1016/j.biomaterials.2007.03.006 ↗
43. Impact of mesoporous silica nanoparticle surface functionality on hemolytic activity, thrombogenicity and non-specific protein adsorption10.1039/c3tb20139b ↗
44. Stability of colloidal silica, sikron and polystyrene latex influenced by the adsorption of polycations of different charge density10.1016/S0927-7757(99)00081-3 ↗
45. Adsorption hysteresis in porous solids10.1006/jcis.1998.5639 ↗
46. Compositional controls on pore-size distribution by nitrogen adsorption technique in the Lower Permian Shanxi Shales, Ordos Basin10.1016/j.jngse.2016.08.026 ↗
47. Mesoporous silica framed by sphere-shaped silica nanoparticles10.1016/j.micromeso.2005.05.004 ↗
48. Structural and thermal characterizations of silica nanoparticles grafted with pendant maleimide and epoxide groups10.1016/j.jcis.2008.08.054 ↗
49. Fabrication of superhydrophobic Eucalyptus wood surface with self-cleaning performance in air and oil environment and high durability10.1016/j.colcom.2020.100264 ↗
50. Core–shell imidazoline–functionalized mesoporous silica superparamagnetic hybrid nanoparticles as a potential theranostic agent for controlled delivery of platinum (II) compound10.2147/IJN.S245135 ↗
51. pH-sensitive controlled release in vitro and pharmacokinetics of ibuprofen from hybrid nanocomposite using amine-modified bimodal mesopores silica as core and poly (methylacrylic acid) as shell
52. Abedi · Mater. Sci. Eng. C · 2019 · 109922
53. Freundlich adsorption isotherms of agricultural by-product-based powdered activated carbons in a geosmin–water system10.1016/S0960-8524(02)00093-7 ↗
54. Bleam · 2017 · 385
55. Applying Freundlich, Langmuir and Temkim models in Cu and Pb soil sorption experiments
56. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan10.1016/j.jconrel.2010.04.029 ↗
57. Influence of functional silanes on hydrophobicity of MCM-41 synthesized from rice husk10.1016/j.stam.2006.11.011 ↗
58. Fabrication, characterization and in vitro evaluation of silibinin nanoparticles: an attempt to enhance its oral bioavailability10.2147/DDDT.S133806 ↗
59. Inclusion and release of fenbufen in mesoporous silica10.1002/jps.22096 ↗
60. In-vitro drug release characterization models
61. Kinetic modeling on drug release from controlled drug delivery systems
62. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation10.1016/j.ijpharm.2005.11.006 ↗